Grimes & Company’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Buy |
23,927
+717
| +3% | +$4.11K | ﹤0.01% | 406 |
|
|
2025
Q1 | $189K | Sell |
23,210
-1,060
| -4% | -$8.65K | 0.01% | 357 |
|
|
2024
Q4 | $229K | Hold |
24,270
| – | – | 0.01% | 348 |
|
|
2024
Q3 | $259K | Hold |
24,270
| – | – | 0.01% | 318 |
|
|
2024
Q2 | $241K | Buy |
24,270
+47
| +0.2% | +$466 | 0.01% | 305 |
|
|
2024
Q1 | $285K | Sell |
24,223
-145
| -0.6% | -$1.71K | 0.01% | 275 |
|
|
2023
Q4 | $346K | Sell |
24,368
-283
| -1% | -$4.02K | 0.01% | 251 |
|
|
2023
Q3 | $300K | Buy |
24,651
+412
| +2% | +$5.01K | 0.01% | 242 |
|
|
2023
Q2 | $304K | Buy |
24,239
+43
| +0.2% | +$540 | 0.01% | 241 |
|
|
2023
Q1 | $268K | Buy |
+24,196
| New | +$268K | 0.01% | 249 |
|